Is India endemic for hydatid disease (Echinococcus granulosus infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is India Endemic to Hydatid Cyst?

Yes, India is endemic for hydatid disease (cystic echinococcosis caused by Echinococcus granulosus), particularly in the northern regions including Kashmir, Punjab, and the northwestern Himalayas. 1

Geographic Distribution in India

According to UK guidelines on eosinophilia management, E. granulosus is endemic in north and east Africa and Asia, with particular emphasis on central Asia 1. More recent guidelines from 2025 specifically identify that in the UK, hydatid disease most commonly presents in migrants from Eastern Europe, Middle East, and North Africa 2.

Regional Evidence from India

Research studies provide concrete evidence of endemicity within India:

  • Kashmir Valley (North India): A sero-epidemiological survey found 5.03% seropositivity among 1,429 asymptomatic subjects, with significantly higher rates (5.79%) in children under 15 years, indicating ongoing active transmission 3

  • Maharashtra State: Seven-year surveillance (2010-2017) of slaughtered animals revealed prevalence rates of 3.00% in cattle, 2.05% in buffalo, 1.28% in pigs, 0.09% in sheep, and 0.01% in goats, with 58 human surgical cases documented during this period 4

  • Punjab: Histopathological studies confirmed endemic presence in food-producing animals 5

  • Northwestern Himalayas (Kangra Valley): Found 12.2% prevalence in sheep and 10.7% in goats among slaughtered animals 6

Genotypes Present in India

Molecular characterization studies identified multiple E. granulosus genotypes circulating in North India 7:

  • G3 (buffalo strain): 53.1% of human cases
  • G1 (sheep strain): 40.62% of human cases
  • G5 (cattle strain): First reported human case in Asia
  • G6 (camel strain): Present in India

This genotypic diversity demonstrates established zoonotic transmission cycles involving multiple livestock species.

Key Risk Factors in Indian Context

The Kashmir study identified significant risk factors 3:

  • Age <15 years (highest seropositivity at 5.79%)
  • Male gender
  • Rural residence
  • Contact with dogs
  • Agricultural/livestock occupation

Clinical Implications

For clinicians practicing in India or evaluating patients from India:

  • Maintain high clinical suspicion for hydatid disease in patients with cystic liver or lung lesions, particularly from northern states
  • The liver is affected in 70% of cases, lungs in 20%, and other sites (CNS, bone, heart) in 10% 1
  • Eosinophilia is typically absent unless cysts are leaking—most asymptomatic cases show normal eosinophil counts 1, 2
  • Diagnosis requires serology (ELISA/immunoblot) combined with imaging (ultrasound/CT/MRI) 1, 2

Treatment Considerations

All hydatid cases should be managed in specialist centers due to significant risks of anaphylaxis and cyst dissemination during interventions 1, 2. Treatment approach depends on cyst size, location, and WHO classification stage, ranging from observation alone for inactive cysts to surgical resection with perioperative albendazole and praziquantel for active disease 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.